
The Union Health Ministry has amended the Drugs Rules, 1945, to allow licensing authorities to bar applicants who submit fake or fabricated data. The amendment was notified through G.S.R. 756(E), dated October…
The Union Health Ministry has amended the Drugs Rules, 1945, to allow licensing authorities to bar applicants who submit fake or fabricated data. The amendment was notified through G.S.R. 756(E), dated October 16, 2025, according to Greater Kashmir.
The debarment can apply to applications filed with either state or central regulators for a specified period. Authorities must first issue a show-cause notice, and applicants can appeal. Earlier, regulators could reject applications or cancel licences. The ministry said reliable scientific data is needed to assess drug quality, safety and efficacy, and warned that fabricated evidence can threaten public health.
Claims that tougher rules alone will clean up drug approvals are premature, while warnings that every rejected application reflects official overreach are equally careless. The useful change is the due process: a notice, a reasoned decision and an appeal. Its value will depend on consistent action against proven fabrication, whether by a large manufacturer or a smaller applicant. The test is how many cases lead to final debarment, and whether those orders withstand appeal.
Source: greaterkashmir.com
This story was synthesised by AI from the source linked above.